BackgroundAdequate disease and treatment-related risk knowledge of people with Multiple Sclerosis (pwMS) is a prerequisite for informed choices in medical encounters. Previous work showed that MS risk knowledge is low among pwMS and role preferences are different in Italy and Germany.ObjectiveWe investigated the level of risk knowledge and role preferences in 8 countries and assessed putative variables associated with risk knowledge.MethodsAn online-survey was performed based on the Risk knowledge questionnaire for people with relapsing-remitting MS (RIKNO 2.0), the electronic Control Preference Scale (eCPS), and other patient questionnaires. Inclusion criteria of participants were: (1) age ≥18 years, (2) a diagnosis of relapsing-remitting ...
Background: As available disease-modifying therapies (DMTs) increase, evaluating benefit/risk presen...
Background: Recent research has raised the level of confidence in a limited number of putative envir...
BackgroundMultiple sclerosis (MS) patients are faced with complex risk-benefit profiles of disease-m...
Background Adequate disease and treatment-related risk knowledge of people with Multiple Sclerosis (...
BackgroundAdequate disease and treatment-related risk knowledge of people with Multiple Sclerosis (p...
Background: Adequate disease and treatment-related risk knowledge of people with Multiple Sclerosis ...
Adequate disease and treatment-related risk knowledge of people with Multiple Sclerosis (pwMS) is a ...
Background: Adequate disease and treatment-related risk knowledge of people with Multiple Sclerosis ...
Background: Risk knowledge is relevant to make informed decisions in multiple sclerosis (MS). The ri...
Background Adequate risk knowledge of patients is a prerequisite for shared decision making but few ...
<div><p>Background</p><p>Adequate risk knowledge of patients is a prerequisite for shared decision m...
ABSTRACT The perception of multiple sclerosis (MS) severity and risk associated with therapies might...
Objective: Shared decision making is increasingly recognized as the ideal model of patient/physician...
Background Adequate risk knowledge of patients is a prerequisite for shared decision making but few ...
Background: Multiple sclerosis (MS) patients are faced with complex risk-benefit profiles of disease-m...
Background: As available disease-modifying therapies (DMTs) increase, evaluating benefit/risk presen...
Background: Recent research has raised the level of confidence in a limited number of putative envir...
BackgroundMultiple sclerosis (MS) patients are faced with complex risk-benefit profiles of disease-m...
Background Adequate disease and treatment-related risk knowledge of people with Multiple Sclerosis (...
BackgroundAdequate disease and treatment-related risk knowledge of people with Multiple Sclerosis (p...
Background: Adequate disease and treatment-related risk knowledge of people with Multiple Sclerosis ...
Adequate disease and treatment-related risk knowledge of people with Multiple Sclerosis (pwMS) is a ...
Background: Adequate disease and treatment-related risk knowledge of people with Multiple Sclerosis ...
Background: Risk knowledge is relevant to make informed decisions in multiple sclerosis (MS). The ri...
Background Adequate risk knowledge of patients is a prerequisite for shared decision making but few ...
<div><p>Background</p><p>Adequate risk knowledge of patients is a prerequisite for shared decision m...
ABSTRACT The perception of multiple sclerosis (MS) severity and risk associated with therapies might...
Objective: Shared decision making is increasingly recognized as the ideal model of patient/physician...
Background Adequate risk knowledge of patients is a prerequisite for shared decision making but few ...
Background: Multiple sclerosis (MS) patients are faced with complex risk-benefit profiles of disease-m...
Background: As available disease-modifying therapies (DMTs) increase, evaluating benefit/risk presen...
Background: Recent research has raised the level of confidence in a limited number of putative envir...
BackgroundMultiple sclerosis (MS) patients are faced with complex risk-benefit profiles of disease-m...